- Review
Anti-Diabetic Therapies and Cancer: From Bench to Bedside
- Dimitris Kounatidis,
- Natalia G. Vallianou,
- Irene Karampela,
- Eleni Rebelos,
- Marina Kouveletsou,
- Vasileios Dalopoulos,
- Petros Koufopoulos,
- Evanthia Diakoumopoulou,
- Nikolaos Tentolouris and
- Maria Dalamaga
Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-diabetic therapies on cancer progression differing across malignancies. Among these therapies, metformin has gained attention for its potential anti-canc...

